News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
566,565 Results
Type
Article (48739)
Company Profile (125)
Press Release (517690)
Multimedia
Podcasts (133)
Webinars (20)
Section
Business (152209)
Career Advice (2494)
Deals (28913)
Drug Delivery (131)
Drug Development (70024)
Employer Resources (162)
FDA (16019)
Job Trends (12451)
News (274797)
Policy (30482)
Tag
Academia (2523)
Academic (1)
Accelerated approval (18)
Adcomms (35)
Allergies (117)
Alliances (37709)
ALS (133)
Alzheimer's disease (1610)
Antibody-drug conjugate (ADC) (229)
Approvals (16028)
Artificial intelligence (401)
Autoimmune disease (92)
Automation (22)
Bankruptcy (315)
Best Places to Work (9498)
BIOSECURE Act (23)
Biosimilars (156)
Biotechnology (72)
Bladder cancer (131)
Brain cancer (44)
Breast cancer (455)
Cancer (3649)
Cardiovascular disease (329)
Career advice (2109)
Career pathing (37)
CAR-T (217)
CDC (57)
Cell therapy (601)
Cervical cancer (30)
Clinical research (58907)
Collaboration (1162)
Company closure (4)
Compensation (913)
Complete response letters (60)
COVID-19 (2708)
CRISPR (72)
C-suite (535)
Cystic fibrosis (127)
Data (4358)
Decentralized trials (2)
Denatured (36)
Depression (105)
Diabetes (409)
Diagnostics (5621)
Digital health (27)
Diversity (6)
Diversity, equity & inclusion (43)
Drug discovery (165)
Drug pricing (189)
Drug shortages (33)
Duchenne muscular dystrophy (197)
Earnings (62204)
Editorial (54)
Employer branding (21)
Employer resources (145)
Events (83554)
Executive appointments (861)
FDA (18431)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (12)
Funding (1066)
Gene editing (154)
Generative AI (33)
Gene therapy (503)
GLP-1 (960)
Government (4225)
Grass and pollen (7)
Guidances (356)
Healthcare (15692)
HIV (42)
Huntington's disease (39)
IgA nephropathy (62)
Immunology and inflammation (239)
Immuno-oncology (22)
Indications (51)
Infectious disease (2928)
Inflammatory bowel disease (168)
Inflation Reduction Act (13)
Influenza (86)
Intellectual property (180)
Interviews (466)
IPO (14365)
IRA (56)
Job creations (3265)
Job search strategy (1733)
Kidney cancer (16)
Labor market (71)
Layoffs (602)
Leadership (36)
Legal (7131)
Liver cancer (83)
Longevity (10)
Lung cancer (523)
Lymphoma (248)
Machine learning (29)
Management (55)
Manufacturing (564)
MASH (137)
Medical device (11686)
Medtech (11705)
Mergers & acquisitions (15380)
Metabolic disorders (1083)
Multiple sclerosis (122)
NASH (22)
Neurodegenerative disease (209)
Neuropsychiatric disorders (59)
Neuroscience (2555)
NextGen: Class of 2025 (5270)
Non-profit (3475)
Now hiring (31)
Obesity (539)
Opinion (262)
Ovarian cancer (123)
Pain (150)
Pancreatic cancer (160)
Parkinson's disease (226)
Partnered (23)
Patents (392)
Patient recruitment (298)
Peanut (51)
People (47092)
Pharmaceutical (35)
Pharmacy benefit managers (28)
Phase I (17591)
Phase II (25465)
Phase III (20826)
Pipeline (2624)
Policy (293)
Postmarket research (2357)
Preclinical (7218)
Press Release (42)
Prostate cancer (194)
Psychedelics (49)
Radiopharmaceuticals (229)
Rare diseases (652)
Real estate (4524)
Recruiting (66)
Regulatory (22628)
Reports (39)
Research institute (2174)
Resumes & cover letters (412)
Rett syndrome (15)
RNA editing (12)
RSV (67)
Schizophrenia (133)
Series A (182)
Series B (139)
Service/supplier (9)
Sickle cell disease (77)
Special edition (24)
Spinal muscular atrophy (134)
Sponsored (40)
Startups (2895)
State (1)
Stomach cancer (17)
Supply chain (93)
Tariffs (96)
The Weekly (96)
Vaccines (1006)
Venture capital (66)
Weight loss (389)
Women's health (47)
Worklife (21)
Date
Today (105)
Last 7 days (610)
Last 30 days (2547)
Last 365 days (29053)
2025 (23942)
2024 (31946)
2023 (35658)
2022 (45824)
2021 (49576)
2020 (46646)
2019 (37898)
2018 (28633)
2017 (28593)
2016 (26821)
2015 (29276)
2014 (22955)
2013 (18774)
2012 (20124)
2011 (20485)
2010 (18791)
Location
Africa (710)
Alabama (60)
Alaska (6)
Arizona (205)
Arkansas (10)
Asia (32832)
Australia (5758)
California (8599)
Canada (2225)
China (722)
Colorado (342)
Connecticut (386)
Delaware (238)
Europe (84345)
Florida (1307)
Georgia (273)
Hawaii (3)
Idaho (39)
Illinois (613)
India (43)
Indiana (370)
Iowa (19)
Japan (300)
Kansas (103)
Kentucky (25)
Louisiana (16)
Maine (68)
Maryland (1150)
Massachusetts (6328)
Michigan (237)
Minnesota (473)
Mississippi (3)
Missouri (102)
Montana (13)
Nebraska (19)
Nevada (96)
New Hampshire (60)
New Jersey (2425)
New Mexico (18)
New York (2304)
North Carolina (1180)
North Dakota (8)
Northern California (4050)
Ohio (235)
Oklahoma (15)
Oregon (30)
Pennsylvania (1777)
Puerto Rico (13)
Rhode Island (29)
South America (1067)
South Carolina (46)
South Dakota (1)
Southern California (3327)
Tennessee (131)
Texas (1274)
United States (30875)
Utah (222)
Virginia (211)
Washington D.C. (71)
Washington State (696)
West Virginia (4)
Wisconsin (83)
Wyoming (1)
566,565 Results for "king s college london".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Zepbound Topples Sales King Keytruda as Lilly Reports 54% YoY Revenue Rise for Q3
Mounjaro and Zepbound contributed more than $10 billion to the $11.98 billion in sales Lilly recorded for key products in the third quarter, despite price decreases for the GLP-1 medicines.
October 30, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London
October 30, 2025
·
1 min read
Business
Recursion Announces Plans to Open New Office in London
Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced plans to open a new office in London’s vibrant King’s Cross neighborhood.
March 11, 2024
·
6 min read
Press Releases
AviadoBio Announces ASPIRE-FTD Phase 1/2 Clinical Trial in the UK at Cambridge University Hospitals NHS Foundation Trust, Cardiff and Vale University Health Board, and University College London
May 15, 2025
·
6 min read
Business
Apollo Therapeutics and King’s College London Enter Into a Strategic Collaboration
Apollo Therapeutics, a biopharmaceutical company focused on translational biology and asset-centric drug development, and King’s College London, announced the formation of a new strategic collaboration.
February 22, 2022
·
3 min read
Press Releases
SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025
September 12, 2025
·
2 min read
Layoffs
Merck Abandons $1.3B R&D Center in London, Boots 125 Employees
Claiming that the domestic market undervalues pharma innovation, Merck has decided to pull the plug on all of its R&D efforts in the U.K.
September 11, 2025
·
1 min read
·
Tristan Manalac
BioMidwest
ENDRA Life Sciences Announces New Clinical Study Partnership with King’s College Hospital, London
ENDRA Life Sciences Inc., a pioneer of enhanced ultrasound technologies, announced that King’s College Hospital, London is now partnering with ENDRA for a clinical study of ENDRA’s Thermo-Acoustic Enhanced Ultrasound device for assessing Non-Alcoholic Fatty Liver Disease.
December 13, 2021
·
6 min read
Immunology and inflammation
Novartis Presents New Data From Potential First Targeted Sjögren’s Treatment
Late-breaking Phase III data show ianalumab, Novartis’ dual-targeted antibody, reduced disease activity and patient burden in Sjögren’s disease, the pharma reported at the American College of Rheumatology Convergence congress on Wednesday.
October 29, 2025
·
3 min read
·
Heather McKenzie
Press Releases
Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology’s 2025 Annual Meeting
October 29, 2025
·
6 min read
1 of 56,657
Next
